Vanguard Group’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.7M | Buy |
|
|||||
|
2025
Q1 | $17.4M | Sell |
|
|||||
|
2024
Q4 | $22.6M | Buy |
|
|||||
|
2024
Q3 | $48.7M | Buy |
|
|||||
|
2024
Q2 | $22.8M | Buy |
|
|||||
|
2024
Q1 | $21M | Buy |
|
|||||
|
2023
Q4 | $17.9M | Buy |
|
|||||
|
2023
Q3 | $19.9M | Buy |
|
|||||
|
2023
Q2 | $25M | Buy |
|
|||||
|
2023
Q1 | $8.41M | Buy |
|
|||||
|
2022
Q4 | $12.1M | Buy |
|
|||||
|
2022
Q3 | $10.7M | Sell |
|
|||||
|
2022
Q2 | $15.9M | Sell |
|
|||||
|
2022
Q1 | $26.4M | Buy |
|
|||||
|
2021
Q4 | $37.9M | Buy |
|
|||||
|
2021
Q3 | $58.2M | Buy |
|
|||||
|
2021
Q2 | $52.8M | Buy |
|
|||||
|
2021
Q1 | $55.6M | Buy |
|
|||||
|
2020
Q4 | $47.9M | Buy |
|
|||||
|
2020
Q3 | $27.2M | Buy |
|
|||||
|
2020
Q2 | $23M | Buy |
|
|||||
|
2020
Q1 | $5.31M | Sell |
|
|||||
|
2019
Q4 | $6.42M | Buy |
|